(2S)-1-[[(4S)-4-(4-Fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1H-pyrimidin-6-yl]methyl]pyrrolidine-2-carboxylic Acid

ID: ALA4559745

PubChem CID: 155558117

Max Phase: Preclinical

Molecular Formula: C22H23FN4O4S

Molecular Weight: 458.51

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)C1=C(CN2CCC[C@H]2C(=O)O)NC(c2nccs2)=N[C@@]1(C)c1ccc(F)cc1

Standard InChI:  InChI=1S/C22H23FN4O4S/c1-22(13-5-7-14(23)8-6-13)17(21(30)31-2)15(12-27-10-3-4-16(27)20(28)29)25-18(26-22)19-24-9-11-32-19/h5-9,11,16H,3-4,10,12H2,1-2H3,(H,25,26)(H,28,29)/t16-,22-/m0/s1

Standard InChI Key:  GQSSEEBYBSGHIV-AOMKIAJQSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    8.9671   -8.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4953   -7.7819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2048   -7.3774    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2048   -6.5522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4953   -6.1357    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7859   -6.5522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7859   -7.3774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0748   -7.7863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0748   -8.6054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3662   -7.3762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6593   -7.7892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0688   -6.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0688   -5.3285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4062   -4.8452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6580   -4.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4787   -4.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7315   -4.8425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6280   -5.0995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0185   -4.5520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4550   -5.8972    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9143   -6.1476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6650   -6.4833    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.2112   -5.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8040   -5.1620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0042   -5.3294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0196   -8.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7327   -9.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2686   -9.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0797   -9.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3548   -8.8947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8306   -8.2659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6077  -10.2912    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  4  3  2  0
  5  4  1  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
  6 12  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 13 17  1  0
 14 18  1  6
 18 19  2  0
 18 20  1  0
  4 21  1  0
 21 22  1  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 21 25  2  0
  2 26  1  0
 26 27  2  0
 28 27  1  0
 29 28  2  0
 30 29  1  0
 31 30  2  0
 26 31  1  0
 29 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4559745

    ---

Associated Targets(non-human)

Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.51Molecular Weight (Monoisotopic): 458.1424AlogP: 2.52#Rotatable Bonds: 6
Polar Surface Area: 104.12Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.09CX Basic pKa: 5.82CX LogP: 0.54CX LogD: -0.75
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.64Np Likeness Score: -0.85

References

1. Qiu Z, Lin X, Zhou M, Liu Y, Zhu W, Chen W, Zhang W, Guo L, Liu H, Wu G, Huang M, Jiang M, Xu Z, Zhou Z, Qin N, Ren S, Qiu H, Zhong S, Zhang Y, Zhang Y, Wu X, Shi L, Shen F, Mao Y, Zhou X, Yang W, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G..  (2016)  Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors.,  59  (16): [PMID:27458651] [10.1021/acs.jmedchem.6b00879]

Source